| Disease | neuroblastoma |
| Symptom | C0029896|ent disease |
| Sentences | 1 |
| PubMedID- 20924375 | Background: the combination of temozolomide (tmz) and irinotecan is a regimen used in neuroblastoma patients with recurrent disease. |
Page: 1